DE60332112D1 - Topische anwendung mindestens eines doppelsträngigen rna-oligonucleotids (ds rna) gegen tyrosinase - Google Patents

Topische anwendung mindestens eines doppelsträngigen rna-oligonucleotids (ds rna) gegen tyrosinase

Info

Publication number
DE60332112D1
DE60332112D1 DE60332112T DE60332112T DE60332112D1 DE 60332112 D1 DE60332112 D1 DE 60332112D1 DE 60332112 T DE60332112 T DE 60332112T DE 60332112 T DE60332112 T DE 60332112T DE 60332112 D1 DE60332112 D1 DE 60332112D1
Authority
DE
Germany
Prior art keywords
double
rna
topical application
rna oligonucleotide
structured
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60332112T
Other languages
English (en)
Inventor
Albert Duranton
Christine Collin-Djangone
Francis Pruche
Jean-Thierry Simonnet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0206796A external-priority patent/FR2840217B1/fr
Application filed by LOreal SA filed Critical LOreal SA
Application granted granted Critical
Publication of DE60332112D1 publication Critical patent/DE60332112D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/13—Decoys

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
DE60332112T 2002-06-03 2003-06-02 Topische anwendung mindestens eines doppelsträngigen rna-oligonucleotids (ds rna) gegen tyrosinase Expired - Lifetime DE60332112D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0206796A FR2840217B1 (fr) 2002-06-03 2002-06-03 Compositions cosmetiques comprenant au moins un oligonucleotide d'arn double brin (dsrna)et leurs utilisations
US38672002P 2002-06-10 2002-06-10
PCT/FR2003/001648 WO2003101376A2 (fr) 2002-06-03 2003-06-02 Utilisation par voie topique d'au moins un oligonucleotide d'arn double brin (ds rna)

Publications (1)

Publication Number Publication Date
DE60332112D1 true DE60332112D1 (de) 2010-05-27

Family

ID=29713354

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60332112T Expired - Lifetime DE60332112D1 (de) 2002-06-03 2003-06-02 Topische anwendung mindestens eines doppelsträngigen rna-oligonucleotids (ds rna) gegen tyrosinase

Country Status (8)

Country Link
EP (1) EP1513482B1 (de)
JP (1) JP4499554B2 (de)
AT (1) ATE464038T1 (de)
AU (1) AU2003255621A1 (de)
CA (1) CA2485111A1 (de)
DE (1) DE60332112D1 (de)
ES (1) ES2342826T3 (de)
WO (1) WO2003101376A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10254214A1 (de) * 2002-11-20 2004-06-09 Beiersdorf Ag Oligoribonukleotide zur Behandlung von degenerativen Hauterscheinungen durch RNA-Interferenz
GB0307914D0 (en) * 2003-04-07 2003-05-14 Univ Dundee Cytochrome p450
JP2007509151A (ja) * 2003-10-21 2007-04-12 ダイアド ファーマシューティカル コーポレーション ５α−レダクターゼ１型及び２型依存性症状を治療するための方法及び組成物
DE102004025881A1 (de) 2004-05-19 2006-01-05 Beiersdorf Ag Oligoribonukleotide zur Beeinflussung des Haarwachstums
WO2006040447A1 (fr) * 2004-10-07 2006-04-20 L'oreal Procédé de traitement cosmétique des fibres kératiniques et utilisation d'un inhibiteur de transglutaminase
WO2006040446A1 (fr) * 2004-10-07 2006-04-20 L'oreal Procédé de mise en forme de fibres kératiniques
FR2885808B1 (fr) 2005-05-19 2007-07-06 Oreal Vectorisation de dsrna par des particules cationiques et utilisation topique.
FR2885813B1 (fr) * 2005-05-19 2008-01-11 Oreal Vectorisation de dsrna par des particules cationiques et leur utilisation sur modele de peau.
US9139850B2 (en) 2005-05-19 2015-09-22 L'oreal Vectorization of dsRNA by cationic particles and topical use
FR2890859B1 (fr) * 2005-09-21 2012-12-21 Oreal Oligonucleotide d'arn double brin inhibant l'expression de la tyrosinase
JP4981381B2 (ja) * 2006-08-04 2012-07-18 株式会社ナリス化粧品 美白用皮膚外用剤
JP2008115101A (ja) * 2006-11-02 2008-05-22 Naris Cosmetics Co Ltd 美白用皮膚組成物
TWI382849B (zh) * 2007-10-29 2013-01-21 Mello Biotech Taiwan Co Ltd 產生藉由基因靜默效應以用於皮膚維護之化妝品的方法以及編碼基因靜默效應物之基因重組核苷酸
FR2940977B1 (fr) * 2009-01-13 2016-11-18 Oreal Utilisation de formes complexes de la proteine de type calmodulin-like skin protein clsp
FR2986233B1 (fr) * 2012-02-01 2014-02-28 Regentis Internat Peptide bifonctionnel
FR3043695B1 (fr) 2015-11-17 2019-10-25 ISP Investments LLC. Procede d'obtention d'un extrait aqueux enrichi en petits arn a partir d'une matiere vegetal et extraits issus du procede
FR3106754B1 (fr) 2020-02-04 2022-01-07 Isp Investments Llc Procede d’obtention d’un extrait aqueux de lavande, compositions comprenant un tel extrait et leurs utilisations cosmetiques
US20230167448A1 (en) * 2020-04-03 2023-06-01 Medrx Co., Ltd. Double Stranded RNA Specifically Inhibiting Expression of IL-23 and Pharmaceutical Composition Comprising Same
FR3116438B1 (fr) 2020-11-23 2022-10-14 Isp Investments Llc Procede d’obtention d’extraits aqueux de feuilles de thes, compositions comprenant de tels extraits et leurs utilisations cosmetiques
FR3125425A1 (fr) 2021-07-22 2023-01-27 Isp Investments Llc Extrait de feuilles de the noir, compositions le comprenant et ses utilisations cosmetiques

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9927444D0 (en) * 1999-11-19 2000-01-19 Cancer Res Campaign Tech Inhibiting gene expression
FR2804960B1 (fr) * 2000-02-11 2005-06-24 Lvmh Rech Nouveaux oligonucleotides et utilisation d'oligonucleotides modulant l'expression de la tyrosinase et de la tyrosinase- related-protein 1 comme agents depigmentants

Also Published As

Publication number Publication date
ES2342826T3 (es) 2010-07-15
WO2003101376A3 (fr) 2004-05-06
AU2003255621A8 (en) 2003-12-19
WO2003101376A2 (fr) 2003-12-11
EP1513482B1 (de) 2010-04-14
JP4499554B2 (ja) 2010-07-07
ATE464038T1 (de) 2010-04-15
CA2485111A1 (fr) 2003-12-11
EP1513482A2 (de) 2005-03-16
JP2005530812A (ja) 2005-10-13
AU2003255621A1 (en) 2003-12-19

Similar Documents

Publication Publication Date Title
DE60332112D1 (de) Topische anwendung mindestens eines doppelsträngigen rna-oligonucleotids (ds rna) gegen tyrosinase
IL160000A0 (en) Methods, compositions and kits relating to chitinases and chitinase-like molecules and imflammatory disease
HK1070004A1 (en) Methods for treating rosacea and telangiectasia
AU2002311903A1 (en) Evaluation of ultraviolet radiation damage to skin using new genemarkers, methods and compositions related thereto
FR2819403B1 (fr) Compositions cosmetiques contenant un fructane, un polysaccharide et un agent benefique et leurs utilisations
DE60104901D1 (de) Hydroverfahrenskatalysator und dessen anwendung
MXPA02007822A (es) Composicion cosmetica, especialmente para el uso en piel envejecida y/o tensa.
ATE340844T1 (de) Stabile, wässerige zusammensetzungen zur behandlung von oberflächen , insbesondere geweben
BR0007430A (pt) Composição tópica compreendendo n-acetilaminoácidos ou n-acetilaldosaminas
EE200300267A (et) Erütropoetiinile reageerivate rakkude, kudede ja elundite kaitsmine, taastamine ja tugevdamine
MXPA05013232A (es) Composicion en forma de pulverizador que comprende un activo farmaceutico, al menos una silicona volatil y una fase aceitosa no volatil.
AR029707A1 (es) Utilizacion de un compuesto metalo-organico para proteger y/o reforzar las materias queratinicas, y procedimiento de tratamiento
EA200970154A1 (ru) Косметические или дерматологические препараты, содержащие n-ацетилцистеин
DE69922152D1 (de) Stabile ascorbinsäure enthaltende zubereitung zur topischen anwendung
ATE278384T1 (de) Zusammensetzung, insbensodere für kosmetika, enthaltend dhea und/oder einen chemische oder biologische vorläufer davon und einen metalloproteinase inhibitor
ATE278382T1 (de) Verwendung von ellagsäure zum schutz gegen verschmutzung
BR0315878A (pt) Melatonina em formulações cosméticas
BRPI0508795A (pt) composição de tratamento capilar, uso da composição, método de tratamento de cabelos e método de fabricação de composição de tratamento capilar
BRPI0400010A (pt) Agente cosmético com proteção contra uv, destinado a ser enxaguado
DE60333391D1 (de) Bleichmittel, hautpräparat zur äusseren anwendung und kosmetikum
BR0115389A (pt) Composição cosmética, método cosmético e uso de composição tópica
BR9903750B1 (pt) utilização não terapêutica de pelo menos um extrato de rosácea do gênero sanguisorba e processo cosmético de pigmentação da pele.
ATE369870T1 (de) Verwendung von nagelrestrukturierungszusammensetzungen für die topische anwendung in onychoschizia
WO2007029188A3 (en) Method of using fabric care compositions to achieve a synergistic odor benefit
SG161309A1 (en) Hair tonic

Legal Events

Date Code Title Description
8364 No opposition during term of opposition